This is more than 8 years old.

Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved

By Associated Press - Tuesday, July 25, 2017

LOS ANGELES (AP) - Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses.

PIANO END ARTICLE RECO

Threat Status: High stakes of int’l democracy Daniel Twining joins Guy Taylor